Investor
News & Events
Financial Reports
Stock Information
Corporate Governance
Contacts & Alerts
Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 12, 2014Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will present at the Baird Industrial Conference in Chicago, Illinois today, Wednesday,...
-
Nov 7, 2014
WASHINGTON, D.C., November 7, 2014 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on December 11, 2014 beginning at 1:00 p.m. ET and...
-
Nov 5, 2014
HemoCue America, a leader in advanced point-of-care testing (POCT) systems, today announced delivery of HemoCue(® )White Blood Cell (WBC) Analyzers to a number of US hospitals. The WBC Analyzers...
-
Oct 16, 2014
Danaher Corporation (NYSE:DHR) today announced results for the third quarter of 2014. Net earnings for the third quarter ended September 26, 2014 were $680.6 million, or $0.95 per share on a...
-
Oct 13, 2014- Danaher plans to merge its Communications business (including Tektronix Communications, Arbor Networks, and Fluke Networks) with NetScout in a tax-free transaction, creating a premier global provider of network management solutions for carrier and enterprise customers.
Danaher Corporation (NYSE: DHR) announced today a definitive agreement with NetScout Systems, Inc. ('NetScout") (NASDAQ: NTCT) to combine Danaher's Communications business with NetScout in a...
-
Sep 22, 2014
Washington, D.C., September 22, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2014 on Thursday, October...
-
Sep 14, 2014- Danaher Corporation announces all-cash tender offer for all publicly held registered shares of Nobel Biocare Holding AG ("Nobel Biocare") at a purchase price of CHF 17.10 per share, representing a total enterprise value of approximately $2.2 billion including debt assumed and net of cash acquired, recommended by Nobel Biocare's Board of Directors.
Danaher Corporation (NYSE:DHR) has entered into a definitive transaction agreement with Nobel Biocare Holding AG ("Nobel Biocare") (SIX Swiss Exchange: NOBN) pursuant to which Danaher Corporation...
-
Sep 9, 2014
WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will present at the Morgan Stanley...
-
Sep 9, 2014
WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on October...
-
Sep 2, 2014
Danaher Corporation (NYSE: DHR) today announced that the Company's Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President...